Adjuvant Therapy
Adjuvant therapy refers to treatment given after the main cancer treatment, typically surgery or radiotherapy, to lower the chance that the cancer comes back. It does not treat active disease, it removes residual microscopic cells that may not have been cleared by the primary treatment.
Medicine used to treat Adjuvant Therapy
How it works in hormone-sensitive cancers
In hormone-receptor-positive breast cancer, the tumour depends on oestrogen or progesterone to grow. Removing that hormonal signal after surgery can significantly cut recurrence risk over the following five to ten years. Anastrozole is one of the most widely used agents in this setting; it belongs to the aromatase-inhibitor class and lowers oestrogen levels in post-menopausal women. You can find it in the oncology support range.
Duration and follow-up
Adjuvant courses typically run for five years, and some guidelines now extend to ten for higher-risk cases. The length is guided by individual tumour characteristics, not a one-size schedule. Regular oncology reviews matter throughout: they track tolerability, bone density (a common concern with long-term aromatase inhibitors), and any new findings.